SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 141 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,419,689 | -24.7% | 407,426 | -14.7% | 0.00% | -25.0% |
Q2 2023 | $12,516,432 | +0.9% | 477,362 | -0.9% | 0.00% | 0.0% |
Q1 2023 | $12,402,536 | +13.0% | 481,839 | +14.2% | 0.00% | 0.0% |
Q4 2022 | $10,978,275 | -8.5% | 422,079 | +0.3% | 0.00% | 0.0% |
Q3 2022 | $12,003,000 | +24.2% | 420,702 | +7.1% | 0.00% | +33.3% |
Q2 2022 | $9,668,000 | -56.7% | 392,697 | -0.8% | 0.00% | -57.1% |
Q1 2022 | $22,335,000 | -6.3% | 395,737 | +2.9% | 0.01% | 0.0% |
Q4 2021 | $23,844,000 | -3.0% | 384,705 | -0.8% | 0.01% | 0.0% |
Q3 2021 | $24,591,000 | -24.0% | 387,624 | -1.3% | 0.01% | -22.2% |
Q2 2021 | $32,374,000 | +11.7% | 392,842 | -0.3% | 0.01% | 0.0% |
Q1 2021 | $28,986,000 | -0.1% | 393,989 | -1.6% | 0.01% | 0.0% |
Q4 2020 | $29,023,000 | +25.6% | 400,209 | -17.4% | 0.01% | +12.5% |
Q3 2020 | $23,110,000 | +10.8% | 484,800 | -2.4% | 0.01% | 0.0% |
Q2 2020 | $20,862,000 | +68.3% | 496,713 | +8.2% | 0.01% | +33.3% |
Q1 2020 | $12,397,000 | -22.5% | 459,145 | +10.5% | 0.01% | 0.0% |
Q4 2019 | $15,988,000 | +103.9% | 415,369 | +14.8% | 0.01% | +100.0% |
Q3 2019 | $7,843,000 | – | 361,772 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 3,081,307 | $71,239,818 | 7.97% |
Finepoint Capital LP | 556,928 | $12,876,175 | 6.41% |
M28 Capital Management LP | 197,700 | $4,570,824 | 5.24% |
Boxer Capital, LLC | 3,421,541 | $79,106,028 | 4.21% |
Deep Track Capital, LP | 3,546,435 | $81,993,577 | 3.16% |
EcoR1 Capital, LLC | 3,460,208 | $80,000,009 | 2.70% |
Orbimed Advisors | 3,968,588 | $91,753,755 | 1.95% |
Artal Group S.A. | 1,816,620 | $42,000 | 1.80% |
SPHERA FUNDS MANAGEMENT LTD. | 319,911 | $7,396,342 | 1.35% |
Perceptive Advisors | 1,520,416 | $35,152,017 | 1.17% |